H
Hualan Biological Bacterin Inc
SZSE:301207
Hualan Biological Bacterin Inc
SZSE:301207
Price:
21.53
CNY
0.65%
Market Closed
Market Cap:
¥12.9B
Relative Value
The Relative Value of one Hualan Biological Bacterin Inc stock under the Base Case scenario is hidden CNY. Compared to the current market price of 21.53 CNY, Hualan Biological Bacterin Inc is hidden .
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Hualan Biological Bacterin Inc Relative Value
HIDDEN
Multiples Across Competitors
Competitors Multiples
Hualan Biological Bacterin Inc Competitors
Hualan Biological Bacterin Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CN |
H
|
Hualan Biological Bacterin Inc
SZSE:301207
|
12.9B CNY | 12.7 | 180 | -338.4 | -338.4 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 746 422.5 | -160 391.7 | -165 649.1 | -163 758.9 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
398.8B USD | 6.7 | 169.8 | 16.4 | 23.3 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
185.3B USD | 5.2 | 26.5 | 18.9 | 18.9 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
177.3B USD | 6.1 | 21.9 | 14.8 | 14.8 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
120B USD | 10.2 | 32.6 | 24 | 25.1 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 087.6 | -532.7 | -682 | -663.8 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
79.5B USD | 5.5 | 17.6 | 14.9 | 17 | |
| AU |
|
CSL Ltd
ASX:CSL
|
86.7B AUD | 3.8 | 19.7 | 9.1 | 11.3 | |
| NL |
|
argenx SE
XBRU:ARGX
|
43.5B EUR | 14.3 | 33.6 | 68 | 69.9 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.7 | -78.2 | -70.5 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
